Hypericin

• Description:

  Hypericin inhibits RANKL-mediated osteoclastogenesis via affecting ERK signalling in vitro and suppresses wear particle-induced osteolysis in vivo.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  504.45

• Molecular Formula:

  C30H16O8

• Notes:

  Research use only, not for human use.

• Receptor:

  Antibacterial|antiviral

• CAS Number:

  548-04-9